Core Viewpoint - The company anticipates a loss attributable to equity holders of approximately RMB 65 million to RMB 78 million for the year ending December 31, 2025, while expecting a profit of about RMB 26.7 million for the year ending December 31, 2024 [1] Group 1: Financial Performance - The overall business environment remains challenging, with sales revenue approximately flat compared to the previous year [1] - Inventory write-offs and provisions have increased due to large-scale product trials and equipment upgrades for new product development from 2022 to 2024, resulting in unsold finished goods [1] - The company recorded a post-tax operating loss of approximately RMB 22 million to RMB 35 million [1] Group 2: Financial Adjustments - Additional post-tax losses are primarily due to adjustments in overall financial planning between companies in the People's Republic of China and Hong Kong [1] - One Hong Kong subsidiary has repaid all interest-bearing loans to another subsidiary in China, with repayment funds sourced from dividends paid by a Chinese subsidiary, leading to expenses and provisions for Chinese dividend withholding tax [1]

SHENGUAN HOLDINGS (GROUP) LIMITED 神冠控股（集團）有限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 佈 全 部 或 任 何 部 分 內 容 而 產 生 或 因 依 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任。 1. 總 體 營 商 環 境 仍 然 充 滿 挑 戰，本 集 團 銷 售 收 入 與 上 年 度 相 比 大 致 上 持 平。 然 而，存 貨 撇 銷 及 撥 備 上 升 主 要 是 由 於 本 集 團 於 二 零 二 二 至 二 零 二 四 年 度期間為研發新產品及安裝新生產線而進行大規模的產品試製和設備改 造，這 些 試 製 產 品 成 品 庫 存 仍 未 能 獲 得 市 場 充 份 消 化。日 常 經 營 業 務 錄 得 稅後虧損約人民幣22,000,000元至人民幣35,000,000元。 （於開曼群島註冊成立的有限公司） （股份代 號：00829） 盈利警告 本 公 佈 乃 神 冠 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 FF301 II. 已發行股份及/或庫存股份變動及足夠公眾持股量的確認 公司名稱: 神冠控股（集團）有限公司 呈交日期: 2026年3月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00829 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 公司名稱: 神冠控股（集團）有限公司 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00829 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.01 HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.01 HKD | | 200,000,000 | 本月底法定/註冊股本總額： HKD 200,000,000 FF301 第 1 頁 共 10 頁 v 1.2.0 截至月份: ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 神冠控股(集團)有限公司 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00829 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | 本月底 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00829 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | 本月底法定/註冊股本總額： HKD 200,000,000 FF301 第 ...

Core Viewpoint - The health industry is experiencing significant growth, leading to the emergence of multiple high-performing stocks in the market [4][5]. Market Performance - The A-share market is currently experiencing high volatility, with major indices like the Shanghai Composite Index retreating after reaching a 10-year high, fluctuating around the 4000-point mark [1]. - The total trading volume for the week was approximately 10.22 trillion yuan, with daily trading around 2 trillion yuan [1]. Financing Trends - Year-to-date, net financing purchases have reached 634 billion yuan, with over 12.6 billion yuan net bought this week [2]. - The power equipment sector saw net purchases exceeding 5.3 billion yuan, while the non-ferrous metals and basic chemicals sectors each received over 3 billion yuan [2]. Banking Sector - The banking sector has been performing strongly, with the index reaching historical highs and a cumulative increase of 94% over the past three years, significantly outpacing the Shanghai Composite Index's 29% increase [3]. - Agricultural Bank of China has shown remarkable growth, with a 66.67% increase this year and a cumulative rise of 317% over four years [3]. Health Industry Growth - The health industry has seen a surge in stock performance, with companies like HeFu China (603122) achieving 12 consecutive trading days of gains, rising over 265% [4]. - Government policies supporting the health industry, such as the "Healthy China 2030" initiative, are contributing to this growth [4][5]. Future Outlook - The health industry is projected to reach a market size of 17.4 trillion yuan by 2025 and 29.1 trillion yuan by 2030 [5]. - The market is expected to stabilize, with structural trends becoming a primary characteristic, as emphasized by the policies aimed at enhancing market resilience [5][6].

Group 1: Market Overview - The health industry continues to strengthen, with several stocks performing exceptionally well [1][6] - A-shares experienced fluctuations, with major indices slightly declining after reaching a 10-year high [1] - The total trading volume for the week was approximately 10.22 trillion yuan, with daily turnover around 2 trillion yuan [1] Group 2: Financing Trends - Cumulative net financing for the year reached 634 billion yuan, with over 12.6 billion yuan net bought this week [2] - The power equipment sector saw over 5.3 billion yuan in net purchases, while the non-ferrous metals and basic chemicals sectors each received over 3 billion yuan [2] - The pharmaceutical and biotechnology sectors attracted over 30.5 billion yuan in net inflows, while the electronics sector faced a net outflow of over 16.1 billion yuan [2] Group 3: Banking Sector Performance - The banking sector has been performing strongly, with indices frequently reaching historical highs [3] - Over the past three years, bank stocks have increased by 94%, significantly outperforming the Shanghai Composite Index [3] - Agricultural Bank of China has shown remarkable growth, with a cumulative increase of 317% over four years [3] Group 4: Policy and Future Outlook - Policies aimed at optimizing bank credit structures and enhancing interest margins are expected to support the banking sector [5] - The health industry is projected to grow significantly, with estimates suggesting a market size of 17.4 trillion yuan by 2025 and 29.1 trillion yuan by 2030 [8] - The market is expected to stabilize, with structural trends becoming more pronounced, particularly in the TMT sector and coal and banking investments [9]

公司名稱: 神冠控股(集團)有限公司 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00829 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 本月 ...

香港联交所最新资料显示，10月2日，董事会主席周亚仙增持神冠控股(00829)421万股，每股均价0.295 港元，总金额约124.20万港元。增持后最新持股数目约为16.31亿股，最新持股比例为50.50%。 ...